CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; none of the 42 sources its claims cite is checked for support yet.

The TLQP-21 Peptide Activates the G-Protein-Coupled Receptor C3aR1 via a Folding-upon-Binding Mechanism

Open access

Abstract

SUMMARY TLQP-21, a VGF-encoded peptide is emerging as a novel target for obesity-associated disorders. TLQP-21 is found in the sympathetic nerve terminals in the adipose tissue and targets the G-protein-coupled-receptor (GPCR) Complement-3a-Receptor1 (C3aR1). So far, the mechanisms of TLQP-21-induced receptor activation remained unexplored. Here, we report that TLQP-21 is intrinsically disordered and undergoes a disorder-to-order transition, adopting an α-helical conformation, upon targeting cells expressing the C3aR1. We determined that the hot spots for TLQP-21 are located at the C-terminus, with mutations in the last four amino acids progressively reducing the bioactivity and, a single site mutation (R21A) or C-terminal amidation abolishing its function completely. Interestingly, the human TLQP-21 sequence carrying a S20A substitution activates the human C3aR1 receptor with lower potency compared to the rodent sequence. These studies reveal the mechanism of action of TLQP-21 and provide molecular templates for designing agonists and antagonists to modulate C3aR1 functions.

Overview

CoChat Summary

TL;DR

TLQP-21 is intrinsically disordered and folds into an α-helix upon binding C3aR1, activating the receptor. Its C-terminal residues, especially Arg21, are required for bioactivity, and human TLQP-21 has lower potency than rodent TLQP-21 at human C3aR1.

Key findings

  • TLQP-21 cross-linked to a ~55 kDa protein corresponding to C3aR1 in 3T3L1 and CHO membranes; the C3aR1 antagonist SB290157 substantially reduced cross-linking. In β-arrestin recruitment assays at human C3aR1, EC50 values were C3a = 3.0 μM, mouse TLQP-21 = 10.3 μM, and human TLQP-21 = 68.8 μM.
  • NMR showed TLQP-21 was unstructured in solution and in membrane-mimetic environments, but adopted α-helical chemical shifts when incubated with C3aR1-expressing 3T3L1 cells, wild-type splenocytes, and N38 cells; this transition did not occur with C3aR1-knockout splenocytes and was partially blocked by SB290157.
  • In rat gastric fundus contraction, 3 μM TLQP-21 produced ~69% of the acetylcholine response, while C3a70-77 produced ~55%. TLQP-11 was inactive up to 10 μM; HFHH-10 gave ~3% at 3 μM, 62% at 6 μM, and 75% at 10 μM. P18A gave ~65% at 3 μM; P19A gave 19% at 3 μM and 35% at 6 μM; human TLQP-21 gave ~20% at 3 μM; R21A and C-terminal amidation abolished activity.
  • TLQP-21 did not increase lipolysis alone but enhanced isoproterenol-induced lipolysis in 3T3L1 adipocytes; R21A did not potentiate isoproterenol-induced lipolysis or AMPK phosphorylation, although it still underwent the helical transition.

Methods

  • Solid-state MAS NMR and solution NMR with 15N/13C-labeled TLQP-21 analogs, plus secondary structure prediction; peptide was incubated with 3T3L1, N38, wild-type or C3aR1-knockout splenocytes, with or without SB290157.
  • Photoaffinity cross-linking using biotin-conjugated TLQP-21 with a benzophenone substitution, membrane preparations from 3T3L1 and CHO cells, and Western blotting; β-arrestin recruitment assay in HTLA cells transfected with C3aR1.
  • Bioassays included rat gastric fundus contraction, truncated and Ala-scanning analogs, and lipolysis/AMPK Western blotting in differentiated 3T3L1 adipocytes; splenocytes were from BALB/cJ and C3aR1 knockout mice.

Limitations

  • Stated: “A full understanding of the similarities in the mechanism of action of TLQP-21 and C3a is currently lacking.” The receptor concentration was unknown in NMR inhibitor experiments, so 5 μM SB290157 was used and only partial receptor saturation was observed.
  • Evident from the text: no atomic structure of the TLQP-21–C3aR1 complex is reported; the α-helical bound conformation is inferred from NMR chemical shifts in cell preparations rather than a receptor-bound structure.
  • Evident from the text: human versus rodent potency differences are described but not fully explained, and some conclusions rely on cell lines and heterologous assays.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.str.2014.10.001

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 23 Not checked · 38 Own results and interpretations

29 more claims

Create a free account to see all 61 claims and to verify the 38 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 56 references

Cited by

See all 71

Metadata

Authors
Cero, C., Vostrikov, V. V., Verardi, R., Severini, C., Gopinath, T., Braun, P. D., Sassano, M. F., Gurney, A., Roth, B. L., Vulchanova, L., Possenti, R., Veglia, G., & Bartolomucci, A.
Affiliations
  • University of Minnesota (US)
  • National Research Council (IT)
  • University of North Carolina at Chapel Hill (US)
  • University of Rome Tor Vergata (IT)
Corresponding author
  • Veglia, Gianluigi
  • Bartolomucci, Alessandro
Venue
Structure
Publisher
Elsevier BV
Published
2014-12
Volume
22
Issue
12
Pages
1744-1753
ISSN
0969-2126 (ISSN-L)
OpenAlex
W2095674992
Cited by
71
References
56
Citations by year
2026: 6 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 8 · 2020: 13 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 7
FWCI
1.88
Type
journal article
Language
en
Open access
Licence
Locations
  • Structure (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health
  • National Institute of Mental Health
  • National Institute on Drug Abuse (R21DA025170)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050456, R01DK102496)
  • National Institute of Dental and Craniofacial Research (R01DE021996)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords
TLQP-21, C3AR1, C3a receptor, G protein-coupled receptor activation, intrinsically disordered peptides, disorder-to-order transition, obesity, C-terminal amidation
MeSH terms
Animals, Female, Models, Molecular, Peptide Fragments, Protein Binding, Protein Conformation, Receptors, Complement, Spleen, Rats, Wistar, Adipocytes, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.